KCNH2I82dup
ClinVar-style identity and transcript context
Limited evidence · n=1 1 observed LQT2 carriers · NA hypothetical affected and NA hypothetical unaffected
Roughly fewer than 1 in 100 people who carry I82dup are estimated to eventually be diagnosed with Long QT type 2 — low risk penetrance, based on 1 carriers reported so far.
Structure: Hotspot. Functional evidence: MAVE not available.
Executive summary
Sources used for interpretationThe LQT2 penetrance estimate combines observed carrier counts with a feature-based model starting point. Other rows summarize supporting annotations for interpretation; not every row is a direct input to the model.
Evidence
Automated ACMG/AMP review prompts
Generated from available data — not a clinical classificationReported carrier data
Model starting point. The penetrance model starts with NA hypothetical affected and NA hypothetical unaffected observations derived from variant features, then updates that starting point with the real carrier counts above. As observed carrier counts grow, this feature-based starting point has less influence.